Physician profile
Travis Ballard
NPI 1477131894
$2,979.49
in general payments reported to CMS, 2019-2025
12 companies · $840 in 2025
The $840 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $399 · 2023: $744 · 2024: $866 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,450.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,972.03 | 2022-2025 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation, Aequalis Flex Revive |
| Depuy Synthes Sales INC. | $343.42 | 2024-2025 | Na, Va-Lcp |
| Coastal Medical Technologies LLC | $171.82 | 2024 | |
| Orthofix Medical, INC. | $144.11 | 2024 | Physio-Stim |
| Medtronic, INC. | $100.64 | 2021 | |
| Medical Device Business Services, INC. | $80.63 | 2025 | Na |
| Polynovo North America LLC | $54.66 | 2025 | Novosorb Btm |
| Mvp Orthopedics INC | $29.17 | 2021 | |
| Amgen INC. | $24.13 | 2025 | Krystexxa |
| Vericel Corporation | $21.24 | 2022 | |
| Kci USA, INC. | $19.43 | 2022 | |
| Ethicon US, LLC | $18.21 | 2024 | Stratafix, Dermabond Prineo, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Ballard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.